Ireland· IE-PA-EU/1/15/1007/001-004
Gardasil 9 suspension for injection. Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
A viral vaccines product containing hpv type 6 l1 protein + hpv type 11 l1 protein + hpv 16 l1 protein + hpv 18 l1 protein, registered in Ireland by Merck Sharp & Dohme BV,. The same ATC class is registered in 3 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Hpv type 6 l1 protein + hpv type 11 l1 protein + hpv 16 l1 protein + hpv 18 l1 protein is registered in 3 of 19 countries.
Countries holding a registration under ATC J07B (viral vaccines), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 2 of them publish a price we can compare per daily dose
Hpv type 6 l1 protein + hpv type 11 l1 protein + hpv 16 l1 protein + hpv 18 l1 protein · ATC J07B
3 / 19 countries
- Czechiaprice
- Finlandprice
- Ireland
The record
At a glance
HPRA (Ireland)- Active substance
- Hpv type 6 l1 protein + Hpv type 11 l1 protein + Hpv 16 l1 protein + Hpv 18 l1 protein
- Manufacturer
- Merck Sharp & Dohme BV,
- Country
- Ireland (IE)
- ATC code
- J07B
- ATC class
- VIRAL VACCINES
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberEU/1/15/1007/001-004
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under J07B
Viral vaccines, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7c7df9e6-bd5d-490b-bba1-be8351b66d04 GET /v1/drugs/7c7df9e6-bd5d-490b-bba1-be8351b66d04?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Suspension for injection",
"routes": [
"Intramuscular use"
],
"source": "hpra",
"atc_all": [
"J07B"
],
"strength": null,
"pa_number": "EU/1/15/1007/001-004",
"substances": [
"Hpv type 6 l1 protein",
"Hpv type 11 l1 protein",
"Hpv 16 l1 protein",
"Hpv 18 l1 protein",
"Hpv type 31 l1 protein",
"Hpv type 33 l1 protein",
"Hpv type 45 l1 protein",
"Hpv type 52 l1 protein",
"Hpv type 58 l1 protein"
],
"legal_basis": "New active substance (Article 8(3) of Directive No 2001/83/EC)",
"market_info": "Unknown",
"authorised_at": "10/06/2015",
"dispensing_status": "Product subject to prescription which may not be renewed (A)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about hpv type 6 l1 protein + hpv type 11 l1 protein + hpv 16 l1 protein + hpv 18 l1 protein.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.